Skip to main content

Table 1 General characteristics and clinical outcomes of patients with different endometrial preparation protocols

From: Retrospective analysis of the endometrial preparation protocols for frozen-thawed embryo transfer cycles in women with endometriosis

Variables

1:GnRH-a-HRT

2:HRT

3:OI

4:NC

P value

No. of cases

451

696

42

859

-

Maternal age at FET, years

32.29ā€‰Ā±ā€‰3.49

32.11ā€‰Ā±ā€‰3.53

32.71ā€‰Ā±ā€‰3.49

32.29ā€‰Ā±ā€‰3.40

0.551

Duration of infertility, years

3.50ā€‰Ā±ā€‰2.34

4.02ā€‰Ā±ā€‰2.67

3.74ā€‰Ā±ā€‰2.36

4.12ā€‰Ā±ā€‰2.68

0.001a

Body mass index, kg/m2

20.75ā€‰Ā±ā€‰2.45

20.80ā€‰Ā±ā€‰2.48

21.25ā€‰Ā±ā€‰2.83

20.69ā€‰Ā±ā€‰2.42

0.607

Infertility diagnosis

Primary infertility, n (%)

61.2%

(276/451)

54.7%

(381/696)

40.5%

(17/42)

59.4%

(510/859)

0.001a

Secondary infertility, n (%)

36.1%(163/451)

43.5%(303/696)

54.8%(23/42)

40%(344/859)

Infertility-freeb

2.7%(12/451)

1.7%(12/696)

4.8%(2/42)

0.6%(5/859)

Infertility etiology, n (%)

Tubal factor

51.2%(231/451)

56.8%(395/696)

61.9%(26/42)

63.7%(547/859)

0.000a

Male factor

49.7%(224/451)

47.6%(331/696)

57.1%(24/42)

47.4%(407/859)

0.556

Other

33.9%(153/451)

35.5%(247/696)

19%(8/42)

24.9%(214/859)

0.000a

endometriosis ASRM stagec

ASRMI-II

14.6%(66/451)

45.7%(318/696)

50%(21/42)

51.2%(440/859)

0.000a

ASRMIII-IV

85.4%(385/451)

54.3%(378/696)

50%(21/42)

48.8%(419/859)

endometriosis complicated with adenomyosis

20.4%(92/451)

3.6%(25/696)

14.3%(6/42)

3.3%(28/859)

0.000a

Ovarian stimulation protocols, n (%)

Long GnRH-a

55.2%(249/451)

74.1%(516/696)

69%(29/42)

79.6%(684/859)

0.000a

GnRH-a ultra-long

12.4%(56/451)

4%(28/696)

0%(0/42)

2.1%(18/859)

GnRH antagonist

24.8%(112/451)

15.1%(105/696)

26.2%(11/42)

12.2%(105/859)

Other protocols

7.5%(34/451)

6.8%(47/696)

4.8%(2/42)

6.1%(52/859)

Gonadotropin dose, IU

2621ā€‰Ā±ā€‰945

2325ā€‰Ā±ā€‰894

2748ā€‰Ā±ā€‰1038

2300ā€‰Ā±ā€‰848

0.000a

No. of oocytes retrieved

12.15ā€‰Ā±ā€‰7.53

15.09ā€‰Ā±ā€‰8.9

14.5ā€‰Ā±ā€‰9.35

15.29ā€‰Ā±ā€‰8.43

0.000a

Blastocyst formation rate

0.60ā€‰Ā±ā€‰0.28

0.56ā€‰Ā±ā€‰0.28

0.59ā€‰Ā±ā€‰0.28

0.56ā€‰Ā±ā€‰0.29

0.313

Type of embryo transferred, n (%)

Cleavage embryo

45.0%(203/451)

42.1%(293/696)

35.7%(15/42)

45.5%(391/859)

0.365

Blastocyst

55.0%(248/451)

57.9%(403/696)

64.3%(27/42)

54.5%(468/859)

No. of embryos transferred

1.58ā€‰Ā±ā€‰0.57

1.71ā€‰Ā±ā€‰0.65

1.48ā€‰Ā±ā€‰0.51

1.78ā€‰Ā±ā€‰0.68

0.000a

No. of good quality embryos transferred

1.15ā€‰Ā±ā€‰0.69

1.13ā€‰Ā±ā€‰0.78

0.93ā€‰Ā±ā€‰0.75

1.12ā€‰Ā±ā€‰0.78

0.287

Rate of good quality embryos transferred

83.8%(378/451)

78.3%(545/696)

69%(29/42)

78.9%(678/859)

0.033a

Clinical Pregnancy

53.2%(240/451)

49.7%(346/696)

54.8%(23/42)

46.8%(402/859)

0.141

Live Birth

43.5%(196/451)

39.8%(277/696)

45.2%(19/42)

39.0%(335/859)

0.397

Early Miscarriage

15.4%(37/240)

18.2%(63/346)

17.4%(4/23)

15.4%(62/402)

0.732

  1. Note: aP<0.05
  2. bInfertility-free: Patients who did not meet the diagnostic criteria for infertility, mainly included patients treated with preimplantation genetic testing(PGT)
  3. cendometriosis ASRM stage: The American Society of Reproductive Medicine distinguishes four stages of endometriosis, where stage I and II are fairly mild types, and stages III and IV are advanced disease